During the last session, Gritstone Bio Inc (NASDAQ:GRTS)’s traded shares were 1.87 million, with the beta value of the company hitting 0.63. At the end of the trading day, the stock’s price was $0.81, reflecting an intraday gain of 10.06% or $0.07. The 52-week high for the GRTS share is $3.33, that puts it down -311.11 from that peak though still a striking 17.28% gain since the share price plummeted to a 52-week low of $0.67. The company’s market capitalization is $86.49M, and the average trade volume was 2.93 million shares over the past three months.
Gritstone Bio Inc (NASDAQ:GRTS) trade information
Gritstone Bio Inc (GRTS) registered a 10.06% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 10.06% in intraday trading to $0.81, hitting a weekly high. The stock’s 5-day price performance is 9.08%, and it has moved by -69.78% in 30 days. Based on these gigs, the overall price performance for the year is -68.49%.
Gritstone Bio Inc (GRTS) estimates and forecasts
Statistics show that Gritstone Bio Inc has outperformed its competitors in share price, compared to the industry in which it operates. Gritstone Bio Inc (GRTS) shares have gone down -56.30% during the last six months, with a year-to-date growth rate more than the industry average at 20.83% against 12.90. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to shrink -6.70% this quarter and then jump 9.70% in the quarter after that. In the rating firms’ projections, revenue will decrease -14.60% compared to the previous financial year.
Revenue for the current quarter is expected to be $1.1 million as predicted by 6 analyst(s). Meanwhile, a consensus of 6 analyst(s) estimates revenue growth to $1.1 million by the end of Jun 2024. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled $2.44 million and $2.5 million respectively. In this case, analysts expect current quarter sales to shrink by -55.00% and then drop by -56.00% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 30.25%. While earnings are projected to return 13.75% in 2024.
GRTS Dividends
Gritstone Bio Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
